Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 104 M130 M87 M114 M105 M109 M 415 M Research & development —————— — Operating income -8 M-1.01 B-1.32 B-750 M-22 M-40 M -2.13 B Non-Operating Income, Total -12 M-66 M69 M37 M-4 M21 M 123 M Interest expense, net of interest capitalized 22 M22 M24 M24 M24 M24 M 96 M Non-Operating Income, excl. Interest Expenses -23 M-73 M37 M13 M-29 M-2 M 19 M Unusual income/expense 11 M7 M8 M01 M-1 M 8 M Pretax income -20 M-1.08 B-1.25 B-713 M-26 M-19 M -2.01 B Equity in earnings —————— — Taxes -3 M-3 M-198 M220 M-7 M-9 M 6 M Non-controlling/minority interest 0-1 M-1 M000 -1 M After tax other income/expense —-11 M0-4 M-4 M-3 M -11 M Net income before discontinued operations -17 M-1.07 B-1.05 B-933 M-19 M-10 M -2.02 B Discontinued operations -8 M-1 M-13 M1 M00 -12 M Net income -25 M-1.07 B-1.07 B-932 M-19 M-10 M -2.03 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -25 M-1.07 B-1.07 B-932 M-19 M-10 M -2.03 B Basic earnings per share (Basic EPS) -1-40.6-40.4-35.39-0.8-0.38 -76.97 Diluted earnings per share (Diluted EPS) -1-40.6-40.4-35.39-0.8-0.38 -76.97 Average basic shares outstanding 26.61 M26.42 M26.33 M26.38 M26.24 M26.35 M — Diluted shares outstanding 26.61 M26.42 M26.33 M26.38 M26.24 M26.35 M — EBITDA 119 M-882 M-1.19 B-405 M113 M97 M -1.39 B EBIT 18 M-983 M-1.29 B-720 M9 M-8 M -2.01 B Cost of revenue 351 M325 M327 M383 M347 M337 M 1.39 B Other cost of goods sold 351 M325 M327 M383 M347 M337 M 1.39 B Depreciation & amortization (cash flow) 101 M101 M103 M315 M104 M105 M 627 M